Candel Therapeutics, Inc.CADLNASDAQ
Loading
Debt-to-equity ratio
3Y CAGR
-57.5%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
0.1x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.04 | -81.9% |
| 2024 | 0.20 | -88.6% |
| 2023 | 1.79 | +273.8% |
| 2022 | 0.48 | +5372.8% |
| 2021 | 0.01 | +121.7% |
| 2020 | -0.04 | +23.2% |
| 2019 | -0.05 | - |